Home > PJ (current issue) > The Society / Daily News | Search

The Pharmaceutical Journal
Vol 272 No 7286 p198
14 February 2004


Society summary


How the CRHP is challenging disciplinary decisions

Two disciplinary decisions have already been to the High Court by the Council for the Regulation of Healthcare Professionals using its powers under Section 29 of the National Health Service Reform and Health Care Professions Act 2002, the Society's Council heard at the February Council meeting.

Jane Wesson, chairman of the CRHP, told the Council that Section 29 gave the CRHP a specific power to review and to scrutinise decisions of regulatory bodies in disciplinary proceedings and to refer to the High Court those that were seen as both unduly lenient and contrary to public safety. The two cases (neither of which concerned the Society) currently going through the High Court would be learning tools on how to exercise that power.

What was more fruitful from Section 29 was the feedback from the scrutiny of the cases that had not gone so far as the High Court. Any recurring themes would be reported back to the CRHP and, more importantly, would be fed back into the regulatory bodies so that they could deal with any specific issues around parts of their disciplinary processes. That would reduce the need to use the Section 29 power.

Mrs Wesson assured the Council that the CRHP would not use its power in a draconian way. It was a learning tool, and the CRHP would work with regulators to improve and professionalise the disciplinary processes. It wanted its work to be open and transparent.

Opening her talk, Mrs Wesson said that the CRHP consisted of 19 people — a lay chair, nine lay members and nine members who represented regulatory bodies. The latter were, by convention, presidents of the relevant regulatory body.

The council had been set up to promote the interests of patients and the public by working to ensure greater consistency between regulatory bodies and by reviewing and instituting best practice. But there was absolutely no way forward in suggesting that one size fitted all. The spectrum of work of health care professionals was huge. The CRHP needed to find out and understand the regulatory bodies’ differences in practice and procedure. Differences that had no purpose had to be eradicated and those that served a purpose had to be explained to the outside world.

The CRHP was looking for best practice so that it could share it. From a scoping study put in hand at the end of 2003 to collect information from all the regulators it was already clear that the Society offered an example of good practice in terms of access for complainants. The Society’s practice of taking complaints over the telephone rather than insisting on them all being written down was hugely forward thinking in terms of people who had difficulties of access. Other regulators required complaints to be made in triplicate and signed in blood!

The CRHP now had a director, Sandy Forrest, and a small staff. The intention was to stay small, focused and flexible, and able to pick up the issues important to regulation that might change with time or as the result of events such as the Shipman case. They wanted CRHP to be seen as a catalyst for change, able to co-ordinate change and bring it together in the interests of the public in a way that had not previously been driven forward in a co-ordinated way.

The CRHP also wanted to be an exemplar for others within the field in the way in which it worked. It would look beyond regulation of health care for good ways of working and good regulation. The target was for health care regulation in the UK to be a world leader.

A refinement of the feedback mechanisms meant that the Society would receive regular feedback on what was happening so that it would understand the thought processes. Where possible, the Society’s Council, with others, would be engaged in the dynamic process of moving change forward. If the Council flagged up priorities, they would be debated and dealt with as priorities and put back out for the regulators to consider.

The CRHP wanted to be co-operative and transparent, working with the regulators to deliver what the public was entitled to expect, which was good service, and, over time, to raise the profile of professionalism, both to the members and to the public.

It also wanted to achieve a greater understanding of what regulation was about. What protected patients were the standards that the professions internalised. They did not do that through the disciplinary process but through all the other things that regulatory bodies did from selecting, through training and through support development to what was to be hoped to be an honourable retirement. That was where the CRHP wanted to put its effort and it could do that in partnership with the regulators.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal